Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score–Matched Study

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae756Source: DataRank Database

The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score–Matched Study is a research paper published in Open Forum Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.97)OA: goldTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Tianqi Ouyang ORCID,Meghan Lee ORCID,Sophia Zhao ORCID,Destiny Harden ORCID,Sherley M. Mejia ORCID

Live enrichment

PubMed:39872811 PMC:PMC11770279 OpenAlex:https://openalex.org/W4405943816

NIH

Grant: R03 DK128533

National Institutes of Health

Grant: 5R03DK128533-02

Effect of Covid-19 on chronic kidney disease progression

FWCI

0.97

Citation Percentile

0.8%

Influential Citations

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofae756/61301237/ofae756.pdf

GOLDhttps://doi.org/10.1093/ofid/ofae756

publisherhttps://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofae756/61301237/ofae756.pdf

publisherhttps://academic.oup.com/ofid/article-pdf/12/1/ofae756/61301237/ofae756.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39872811

Fields of Study

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsMedicine0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

MedicineRitonavirHazard ratioInternal medicineAdverse effectKidney diseaseProportional hazards modelPropensity score matchingAtazanavirConfidence intervalImmunologyViral loadHuman immunodeficiency virus (HIV)Chronic Kidney DiseaseMajor Adverse Cardiovascular EventCovid-19Nirmatrelvir-RitonavirInfectious Diseases in Special Populations

Sustainable Development Goals

SDG 0: Good health and well-being

The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score–Matched Study

FAIR Checklist

Authors (9)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)